Ionis Pharmaceuticals (IONS) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2024, Ionis Pharmaceuticals (IONS) reported revenue of $227 million, down 30.2% over the same period last year. EPS came in at -$0.66, compared to -$0.06 in the year-ago quarter.The reported revenue represents a surprise of +65.19% over the Zacks Consensus Estimate of $137.42 million. With the consensus EPS estimate being -$1.12, the EPS surprise was +41.07%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectation ...